Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
International Journal of Molecular Sciences
|
December 15, 2019
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
Sophia Stock, Michael Schmitt, Leopold Sellner
Current Hematologic Malignancy Reports
|
January 13, 2012
Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?
Leopold Sellner, Sascha Dietrich, Peter Dreger, et al.
European Journal of Haematology
|
September 29, 2020
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database
Christof Scheid, Igor W Blau, Leopold Sellner, et al.
Oncoimmunology
|
May 8, 2015
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells
Srinivas Mamidi, Simon Höne, Claudia Teufel, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 13, 2020
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany
Edin Basic, Mathias Kappel, Arpit Misra, et al.
Journal of Medicinal Chemistry
|
August 13, 2013
Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells
Paul Marzenell, Helen Hagen, Leopold Sellner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 2009
Normal-tissue radioprotection by overexpression of the copper-zinc and manganese superoxide dismutase genes
Marlon R Veldwijk, Carsten Herskind, Leopold Sellner, et al.
Experimental Hematology
|
May 23, 2008
Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells
Leopold Sellner, Marius Stiefelhagen, Jürgen A Kleinschmidt, et al.
Leukemia & Lymphoma
|
February 18, 2011
Efficient gene transfer with pseudotyped recombinant adeno-associated viral vectors into human chronic myelogenous leukemia cells
Leopold Sellner, Marlon R Veldwijk, Jürgen A Kleinschmidt, et al.
Genetic Vaccines and Therapy
|
September 16, 2008
Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line
Marius Stiefelhagen, Leopold Sellner, Jürgen A Kleinschmidt, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
International Journal of Molecular Sciences
|
December 15, 2019
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
Sophia Stock, Michael Schmitt, Leopold Sellner
Current Hematologic Malignancy Reports
|
January 13, 2012
Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?
Leopold Sellner, Sascha Dietrich, Peter Dreger, et al.
European Journal of Haematology
|
September 29, 2020
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database
Christof Scheid, Igor W Blau, Leopold Sellner, et al.
Oncoimmunology
|
May 8, 2015
Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells
Srinivas Mamidi, Simon Höne, Claudia Teufel, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
July 13, 2020
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany
Edin Basic, Mathias Kappel, Arpit Misra, et al.
Journal of Medicinal Chemistry
|
August 13, 2013
Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells
Paul Marzenell, Helen Hagen, Leopold Sellner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
August 5, 2009
Normal-tissue radioprotection by overexpression of the copper-zinc and manganese superoxide dismutase genes
Marlon R Veldwijk, Carsten Herskind, Leopold Sellner, et al.
Experimental Hematology
|
May 23, 2008
Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells
Leopold Sellner, Marius Stiefelhagen, Jürgen A Kleinschmidt, et al.
Leukemia & Lymphoma
|
February 18, 2011
Efficient gene transfer with pseudotyped recombinant adeno-associated viral vectors into human chronic myelogenous leukemia cells
Leopold Sellner, Marlon R Veldwijk, Jürgen A Kleinschmidt, et al.
Genetic Vaccines and Therapy
|
September 16, 2008
Application of a haematopoetic progenitor cell-targeted adeno-associated viral (AAV) vector established by selection of an AAV random peptide library on a leukaemia cell line
Marius Stiefelhagen, Leopold Sellner, Jürgen A Kleinschmidt, et al.
Page
of 5